Aimmune Stock Price, News & Analysis
AIMT
NASDAQ
Company Description
Aimmune (NASDAQ: AIMT) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
AIMT stock has gained 42.5% over the past year.
This page provides a comprehensive overview of AIMT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+42.46%
Performance 1 year
$0.0
65.5M
Aimmune (AIMT) stock. Over the past 12 months, the stock has gained 42.5%.
Latest News
Aimmune has 1 recent news article. Key topics include clinical trial. View all AIMT news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
AIMT Company Profile & Sector Positioning
Aimmune (AIMT) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.